| CXSL1500030 | SHR-1309注射液 | pertuzumab | Injection | Biological Products(2) | New Drug Application | 2015-05-13 | 上海恒瑞医药有限公司 | Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2017-02-21 | view |
| JXSL1300083 | 帕妥珠单抗 | pertuzumab | Injection | Biological Products | Import Drug Application | 2014-01-03 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Pharma (Schweiz) Ltd | Certificate Issued | 2015-10-19 | view |
| JXSS2200027 | 帕妥珠单抗曲妥珠单抗注射液（皮下注射） | pertuzumab;trastuzumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-07-27 | | F Hoffmann-La Roche Ltd(Switzerland);Roche Pharma (Schweiz) AG | | | view |
| JXSS2200026 | 帕妥珠单抗曲妥珠单抗注射液（皮下注射） | pertuzumab;trastuzumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-07-27 | | Roche Pharma (Schweiz) AG;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JXSL0800003 | 帕妥珠单抗注射剂 | pertuzumab | Injection | Biological Products | Import Drug Application | 2008-03-12 | F.Hoffmann-La Roche Ltd. | F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2010-01-29 | view |
| JYSB2000696 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-01-05 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd | Certificate Issued | 2021-03-17 | view |
| JXSL1300034 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2013-05-23 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2015-08-10 | view |
| JYSB2300009 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2023-01-17 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSL1800044 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2018-10-29 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2018-10-26 | view |
| JYSB2400254 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2024-12-09 | | Genentech Inc;Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JYSB2000386 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) Ltd | Filed | 2020-09-02 | view |
| JYSB2200111 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2022-06-30 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSS1700018 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Import Drug Application | 2018-01-02 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd;Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) | Certificate Issued | 2018-12-19 | view |
| CXSS2300038 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products(3.3) | New Drug Application | 2023-05-24 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSB1900363 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-01-19 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | Certificate Issued | 2020-03-24 | view |
| CXSS2300002 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-10 | | QILU Pharmaceutical Co Ltd | | | view |
| JYSB1800226 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2018-10-26 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | Certificate Issued | 2018-12-19 | view |
| CXSS2400134 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products(3.3) | New Drug Application | 2024-12-04 | | Shanghai Henlius Biologics Co Ltd | | | view |
| JYSB2000140 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2020-05-06 | 罗氏（中国）投资有限公司 | Roche (China) Holding Ltd;Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | In Review | 2020-05-01 | view |
| JYSB2101061 | 帕妥珠单抗注射液 | pertuzumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
